Medline (MDLN) Receivables (2024 - 2026)

Medline (MDLN) has reported Receivables for 3 consecutive years, with $3.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables changed N/A year-over-year to $3.7 billion in Q2 2026; TTM through Jun 2026 was $3.7 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $3.5 billion, up 9.75% from the prior year.
• Receivables was $3.7 billion for Q2 2026 at Medline, roughly flat from $3.7 billion in the prior quarter.
• Over five years, Receivables peaked at $3.7 billion in Q1 2026 and troughed at $3.2 billion in Q4 2024.
• A 3-year average of $3.5 billion and a median of $3.6 billion in 2025 frame the typical range for Receivables.
• The widest YoY moves for Receivables: up 9.75% in 2025, down 9.75% in 2025.
• Over 3 years, Receivables stood at $3.2 billion in 2024, then grew by 9.75% to $3.5 billion in 2025, then gained by 3.62% to $3.7 billion in 2026.
• The last three Receivables figures came in at $3.7 billion (Q2 2026), $3.7 billion (Q1 2026), and $3.5 billion (Q4 2025), per Business Quant data.